Box score
Context Therapeutics Inc.
Reported $100M sold in a new Form D filed May 16, 2024 (Philadelphia, Pennsylvania).
- Biggest raise
- $100M filed May 16, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- Philadelphia, Pennsylvania
- Season rank
- #49 of 1,389 in the Bio & Health League; #198 of 12,443 overall (2024)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-05-16 | New notice | $100M | $100M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1842952.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Aclaris Therapeutics, Inc. | Bio & Health | $80M |
| 2 | Third Arc Bio, Inc. rookie | Bio & Health | $72.5M |
| 3 | Interius BioTherapeutics, Inc. | Bio & Health | $51.4M |
| 4 | Cagent Vascular, Inc. | Bio & Health | $28.7M |
| 5 | PeopleOne Health, Inc. | Bio & Health | $23.7M |
| 6 | Reunion Neuroscience Management, Inc. rookie | Bio & Health | $16.9M |